More EMA issues new Guideline on "Chemistry of Active Substances"
More FDA Perspective on Risk Management and its Influence on Quality - Inspection Deficiencies 2015
More EMA's Concept Paper on Non-Clinical Documentation for Herbal Medicinal Products published
More ICH M9: Biopharmaceutics Classification System-based Biowaivers
More FDA's Quality Metrics Initiative starts with voluntary Phase
More Generics: FDA´s New Guidance on Prior Approval Supplements
More Opportunities for Reducing Sampling and Testing of Starting Materials